Civic Intelligence

Knowledge Recovery Fund International DBA Knowledge Recovery Institute

EIN 74-3223951 • 501(c)3 • Nyc, NY

Profile

Drug Research for Neglected Diseases and Mental Health for Opioid/Substance Use Disorder (OUD/SUD) and Antiaddiction product Ibogaine in preparation for FDA Investigative New Drug Development for Opioid Abatement program in NYS. KRFI has prepared the Ibogaine Endabuse(R) and Tabernanthe Iboga/Voacanaga Iboga Drug Master Files IP provision for Private Public Sector Partnership for health equity, accessibility through the Clinical Trial Management Platform and drug supply chain security hyperledger.

4 East 89 StreetNyc, NY 10128
Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

77th percentile

0.17x

Higher debt load relative to assets than 77% of similar nonprofits.

NTEE F • <$500k nonprofits • Source year 2023

Liabilities / Revenue

82nd percentile

0.14x

Higher debt load relative to revenue than 82% of similar nonprofits.

NTEE F • <$500k nonprofits • Source year 2023

Net Margin

83rd percentile

51%

Higher net margin than 83% of similar nonprofits.

NTEE F • <$500k nonprofits • Source year 2023

Top Officer Pay

76th percentile

$0

Higher top officer pay than 76% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

NTEE F • <$500k nonprofits • Source year 2023

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2023

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2023

Balance Sheet
Liabilities / Assets77th percentile

Assets

$72,500

No earlier filing loaded for comparison.

Liabilities

$12,500

No earlier filing loaded for comparison.

Net Assets

$60,000

No earlier filing loaded for comparison.

Operations
Liabilities / Revenue82nd percentileNet Margin83rd percentile

Revenue

$89,800

No earlier filing loaded for comparison.

Expenses

$44,000

No earlier filing loaded for comparison.

Net Income

$45,800

No earlier filing loaded for comparison.

Trend Graphs

Balance Sheet Trend

Asset GrowthScore unavailable

Grouped bars show assets, liabilities, and net assets across loaded filings.

$80K$60K$40K$20K$0Assets 2023: $72,500Liabilities 2023: $12,500Net Assets 2023: $60,0002023

Highlighted filing

2023

Assets$72,500
Liabilities$12,500
Net Assets$60,000
Open 2023 Filing

Operations Trend

Revenue GrowthScore unavailable

Revenue, expenses, and net income by year, with the latest filing highlighted.

$100K$50K$0Revenue 2023: $89,800Expenses 2023: $44,000Net Income 2023: $45,8002023

Highlighted filing

2023

Revenue$89,800
Expenses$44,000
Net Income$45,800
Open 2023 Filing

Filings

Most recent year

2023 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$72,500
Liabilities
$12,500
Net assets
$60,000
Revenue
$89,800
Expenses
$44,000
Net income
$45,800
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2023Detailed filing. Detailed filing data is available for this year.$72.5$12.5$60.0$89.8$44.0$45.8
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Apr 1, 2022 to Mar 31, 2023
Signed
Jun 6, 2025
Return Version
2022v5.0
Gross Receipts
$92,200
Mission and Program Overview

Mission

Drug Research for Neglected Diseases and Mental Health for Opioid/Substance Use Disorder (OUD/SUD) and Antiaddiction product Ibogaine in preparation for FDA Investigative New Drug Development for Opioid Abatement program in NYS. KRFI has prepared the Ibogaine Endabuse(R) and Tabernanthe Iboga/Voacanaga Iboga Drug Master Files IP provision for Private Public Sector Partnership for health equity, accessibility through the Clinical Trial Management Platform and drug supply chain security hyperledger.

Program Services

DescriptionGrantsExpenses
Drug Research for Neglected Diseases and Mental Health for Opioid/Substance Use Disorder (OUD/SUD) and Antiaddiction product Ibogaine in preparation for FDA Investigative New Drug Development for Opioid Abatement program in NYS. KRFI has prepared the Ibogaine Endabuse(R) and Tabernanthe Iboga/Voacanaga Iboga Drug Master Files IP provision for Private Public Sector Partnership for health equity, accessibility through the Clinical Trial Management Platform and drug supply chain security hyperledger.$0$0
Compensation and Service Providers
Top Officer Pay76th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
MyungHi Sonserai LeeCEOFT$0--
Agostino von HassellVeterans Program DirectorPT$0--
Douglas AcostsLegal AdvisorPT$0--
Andres S CordovaMedia DirectorPT$0--
Gene WeissDirectorPT$0--
Filing and Contact Details

Filer

Filer Name
Knowledge Recovery Fund International
EIN
74-3223951
Phone
2127223960
Address
4 East 89 Street, NYC, NY 10128

Signing Officer

Name
MyungHi Sonserai Lee
Title
CEO
Phone
2127223960
Signed
2025-06-06
Supplemental Narrative

Additional Explanations

Form 990-EZ, Part I, Line 8

“Description;Amount^Jewelry;7000|Laboratory Equipment;0^Total;7000^”

Form 990-EZ, Part I, Line 16

“Description;Amount^NJ Public storage for Laboratory Equipment;12000^Total;12000^”

Form 990-EZ, Part I, Line 20

“Description;Amount^Jewelry donation;14200^Total;14200^”

Form 990-EZ, Part II, Line 24

“Description;EOY Amount^Laboratory Equipment;70000^Total;70000^”

Form 990-EZ, Part II, Line 26

“Description;EOY Amount^NJS Laboratory Storaging at Public Storage;12500^Total;12500^”

Raw XML Appendix162 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd00
IRS990EZ/BenefitsPaidToOrForMembersAmt00
IRS990EZ/BooksInCareOfDetail/PersonNm0MyungHI Sonserai Lee
IRS990EZ/BooksInCareOfDetail/PhoneNum02127223960
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt04 East 89th Street
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0NYC
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NY
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd010128
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt00
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt02500
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd00
IRS990EZ/ContributionsGiftsGrantsEtcAmt070200
IRS990EZ/CostOfGoodsSoldAmt00
IRS990EZ/CostOrOtherBasisExpenseSaleAmt01200
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd00
IRS990EZ/EngagedInExcessBenefitTransInd00
IRS990EZ/ExcessOrDeficitForYearAmt045800
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt00
IRS990EZ/FiledScheduleAInd01
IRS990EZ/ForeignFinancialAccountInd00
IRS990EZ/ForeignOfficeInd00
IRS990EZ/Form1120PolFiledInd00
IRS990EZ/Form990TotalAssetsGrp/BOYAmt00
IRS990EZ/Form990TotalAssetsGrp/EOYAmt072500
IRS990EZ/FundraisingGrossIncomeAmt03000
IRS990EZ/GainOrLossFromSaleOfAssetsAmt010800
IRS990EZ/GamingGrossIncomeAmt00
IRS990EZ/GrantsAndSimilarAmountsPaidAmt00
IRS990EZ/GrossProfitLossSlsOfInvntryAmt00
IRS990EZ/GrossReceiptsAmt092200
IRS990EZ/GrossSalesOfInventoryAmt00
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InvestmentIncomeAmt00
IRS990EZ/LandAndBuildingsGrp/BOYAmt00
IRS990EZ/LandAndBuildingsGrp/EOYAmt00
IRS990EZ/LobbyingActivitiesInd00
IRS990EZ/MadeLoansToFromOfficersInd00
IRS990EZ/MembershipDuesAmt00
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt00
IRS990EZ/NetAssetsOrFundBalancesEOYAmt060000
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt00
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt060000
IRS990EZ/OccupancyRentUtltsAndMaintAmt028200
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt040
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt115
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt210
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt310
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt410
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0MyungHi Sonserai Lee
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1Agostino von Hassell
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2Douglas Acosts
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3Andres S Cordova
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4Gene Weiss
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0CEO
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Veterans Program Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2legal advisor
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3Media director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4director
IRS990EZ/OperateHospitalInd00
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd00
IRS990EZ/OrganizationHadUBIInd00
IRS990EZ/OtherAssetsTotalDetail/BOYAmt00
IRS990EZ/OtherAssetsTotalDetail/EOYAmt070000
IRS990EZ/OtherChangesInNetAssetsAmt014200
IRS990EZ/OtherExpensesTotalAmt012000
IRS990EZ/OtherRevenueTotalAmt07000
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd00
IRS990EZ/PrimaryExemptPurposeTxt0Drug Research for Neglected Diseases and Mental Health for Opioid/Substance Use Disorder (OUD/SUD) and Antiaddiction product Ibogaine in preparation for FDA Investigative New Drug Development for Opioid Abatement program in NYS. KRFI has prepared the Ibogaine Endabuse(R) and Tabernanthe Iboga/Voacanaga Iboga Drug Master Files IP provision for Private Public Sector Partnership for health equity, accessibility through the Clinical Trial Management Platform and drug supply chain security hyperledger.
IRS990EZ/PrintingPublicationsPostageAmt01800
IRS990EZ/ProgramServiceRevenueAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0Drug Research for Neglected Diseases and Mental Health for Opioid/Substance Use Disorder (OUD/SUD) and Antiaddiction product Ibogaine in preparation for FDA Investigative New Drug Development for Opioid Abatement program in NYS. KRFI has prepared the Ibogaine Endabuse(R) and Tabernanthe Iboga/Voacanaga Iboga Drug Master Files IP provision for Private Public Sector Partnership for health equity, accessibility through the Clinical Trial Management Platform and drug supply chain security hyperledger.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt00
IRS990EZ/ProhibitedTaxShelterTransInd00
IRS990EZ/RelatedOrganizationCtrlEntInd00
IRS990EZ/SalariesOtherCompEmplBnftAmt02000
IRS990EZ/SaleOfAssetsGrossAmt012000
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SchoolOperatingInd00
IRS990EZ/SpecialEventsDirectExpensesAmt01200
IRS990EZ/SpecialEventsNetIncomeLossAmt01800
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0NY
IRS990EZ/SubjectToProxyTaxInd00
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt00
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt012500
IRS990EZ/TanningServicesProvidedInd00
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt044000
IRS990EZ/TotalProgramServiceExpensesAmt00
IRS990EZ/TotalRevenueAmt089800
IRS990EZ/TransactionWithControlEntInd00
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990ScheduleA/First5Years170Ind0X
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt080000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt080000
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt012500
IRS990ScheduleA/PublicSupportTotal170Amt080000
IRS990ScheduleA/TestPublicSafetyInd0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt080000
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt00
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt080000
IRS990ScheduleA/TotalSupportAmt080000
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Description;Amount^Jewelry;7000|Laboratory Equipment;0^Total;7000^
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1Description;Amount^NJ Public storage for Laboratory Equipment;12000^Total;12000^
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2Description;Amount^Jewelry donation;14200^Total;14200^
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3Description;EOY Amount^Laboratory Equipment;70000^Total;70000^
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4Description;EOY Amount^NJS Laboratory Storaging at Public Storage;12500^Total;12500^
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Form 990-EZ, Part I, Line 8
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Form 990-EZ, Part I, Line 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Form 990-EZ, Part I, Line 20
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3Form 990-EZ, Part II, Line 24
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4Form 990-EZ, Part II, Line 26
ReasonableCauseExplanation/ExplanationTxt0The scheduled application were delayed and Programs lauched in August.
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/PersonNm0MyungHi Sonserai Lee
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0CEO
ReturnHeader/BusinessOfficerGrp/PhoneNum02127223960
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-06-06
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0KNOWLEDGE RECOVERY FUND INTERNATIONAL
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0dba Knowledge Recovery Institute
ReturnHeader/Filer/BusinessNameControlTxt0KNOW
ReturnHeader/Filer/EIN0743223951
ReturnHeader/Filer/PhoneNum02127223960
ReturnHeader/Filer/USAddress/AddressLine1Txt04 East 89 Street
ReturnHeader/Filer/USAddress/CityNm0NYC
ReturnHeader/Filer/USAddress/StateAbbreviationCd0NY
ReturnHeader/Filer/USAddress/ZIPCd010128
ReturnHeader/IRSResponsiblePrtyInfoCurrInd01
ReturnHeader/ReturnTs02025-06-21T16:13:22-07:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02022-04-01
ReturnHeader/TaxPeriodEndDt02023-03-31
ReturnHeader/TaxYr02022

Document Assets

No mirrored PDF or thumbnail assets are attached yet.